Drug survival and reasons for discontinuation of the first course of biological therapy in 301 juvenile idiopathic arthritis patients
The objective of this study was to determine long-term effectiveness and safety of 1<sup>st</sup> biological treatment (BT) in a cohort of 301 juvenile idiopathic arthritis (JIA) patients (pts), non-responders to disease-modifying antirheumatic drugs (DMARDs), in terms of drug survival (...
Saved in:
Main Authors: | M. Romano (Author), I. Pontikaki (Author), M. Gattinara (Author), I. Ardoino (Author), C. Donati (Author), P. Boracchi (Author), P.L. Meroni (Author), V. Gerloni (Author) |
---|---|
Format: | Book |
Published: |
PAGEPress Publications,
2014-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Anakinra in systemic juvenile idiopathic arthritis (soJIA) non responsive to antiTNF
by: Pontikaki I, et al.
Published: (2008) -
Efficacy of a second TNF blocker, when the first one failed, in patients with juvenile idiopathic arthritis (JIA)
by: Salmaso A, et al.
Published: (2008) -
Side effects of anti-TNFa therapy in juvenile idiopathic arthritis
by: Elisabetta Valcamonica, et al.
Published: (2011) -
Long-term evaluation of infliximab in the treatment of persistently active juvenile idiopathic arthritis refractory to conventional therapy
by: M. Gattinara, et al.
Published: (2011) -
Temporomandibular joint involvement in juvenile idiopathic arthritis: treatment with an orthodontic appliance
by: M. Gattinara, et al.
Published: (2011)